Navigation Links
Weight Loss Without Hunger!
Date:2/13/2009

Full Sense(TM) Device completes successful clinical evaluation

GRAND RAPIDS, Mich., Feb. 13 /PRNewswire/ -- Sentinel Group announced the completion of the first study of the Full Sense(TM) Device. The study was conducted at Galenia Hospital in Cancun, Mexico by American doctors Randal Baker MD, James Foote MD and Mexican doctor Jorge Trevino MD. The study protocol was designed to have the devices implanted for 6 weeks to evaluate weight loss, satiety (lack of hunger), safety, and removability.

The Full Sense(TM) Device is a stent like device placed through the mouth into the top of the stomach to cause satiety thus decreased hunger and increased fullness. It causes satiety by placing pressure on the bottom of the esophagus and the top of the stomach.

Patients not only lost significant weight in the study but also noted significant satiety with the device in place. Without the device they noted extreme hunger before meals whereas with the pressure from the Full Sense(TM) Device they experienced at most slight to no hunger before meals. The devices were removed safely and patients have stopped losing weight and are beginning to regain the weight that they had lost.

"The patients were extremely happy with the lack of hunger and resulting weight loss. They did not want the devices removed but reluctantly underwent removal per the protocol to demonstrate that the device could be easily removed," said Fred Walburn, PhD., President of Sentinel Group. "This technology represents potentially a new era of safe non-surgical weight loss treatment and offers hope for the millions of Americans who need treatment for obesity but can't afford the cost or possible complications of traditional weight loss surgery."

"Obesity is increasingly causing devastating effects on individuals and our society as a whole. This technology, I believe, offers the best opportunity yet to deliver consistent satiety and weight loss. Even many people with traditional weight loss surgery are experiencing significant hunger and subsequent weight regain. The potential to deliver satiety without classic incisions and surgery will give hope to many more people struggling with weight and weight related medical conditions," stated Randal Baker MD.

"The patients were very pleased with the results of the Full Sense(TM) Device," said Dr. Trevino, Head of Bariatric Surgery. "They are asking for the device to be implanted again!"

ABOUT GALENIA

The Galenia Hospital located in Cancun, Quintana Roo, Mexico is a modern facility with state of the art equipment which goes beyond the everyday services, with highly trained doctors and a wide range of medical specialties along with experienced people working for health care of national and international patients.

ABOUT SENTINEL GROUP

Sentinel Group is a medical device development company founded to commercialize patents owned by its principals and to assist physician inventors in commercializing their ideas. The company's intellectual property portfolio includes technologies in the areas of: bariatrics, colorectal anastomoses, diverticulitis, hiatal hernia, depression, Natural Orifice Translumenal Endoscopic Surgery (NOTES), Endoscopy and GERD. The Company's first product is the Full Sense(TM) Bariatric Device.

The Full Sense(TM) Device is not available in all markets pending regulatory clearance. Sentinel Group(R) and Full Sense(TM) Device are trademarks of Sentinel Group LLC.


'/>"/>
SOURCE Sentinel Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Losing Weight with Chocolate on Valentine's Day
2. Employee Weight Loss Programs Offered By Half of Employers Who Provide Wellness Programs
3. Losing weight can cure obstructive sleep apnea in overweight patients
4. How Much Weight Can They Lose in 90 Days?
5. ADA releases updated position statement on weight management
6. World Cancer Day Highlights Link Between Overweight and Cancer
7. Divorce, antidepressants, or weight gain/loss can add years to your face
8. Divorce, Antidepressants, or Weight Gain/Loss Can Add Years to Your Face
9. Growth hormone treatment after weight loss surgery prevents loss of muscle mass
10. Nutrition 21 Launches Breakthrough Weight Management Product: Iceland Health(R) Appetite Control Formula
11. Dallas – Fort Worth Bariatric Surgeon Dr. David Kim One of Few in America Selected to Perform New Weight Loss Surgery Procedure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: the personal journey of Bob Massey and ... creation of published authors, Bob and Margaret Massey. Bob Massey is small in stature ... and leather tough." His love for others is apparent in all of his life ...
(Date:5/24/2017)... ... May 24, 2017 , ... Last ... Mary Ellen, hospital employees, and town officials to celebrate the grand opening of ... developed by Rendina as part of its ongoing relationship with RWJBarnabas Health, New ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... dental implants in Bayside, NY, who have now spent 10 years as clinical ... New York University (NYU) College of Dentistry. Through the program, private practitioners receive ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Curry Leavitt, a ... (High-Performance Periodontal Practice) continuing education (CE) series. As a compassionate and dedicated clinician, ... by attending numerous CE courses each year. His recent course, Course II of ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... pediatric dentistry options for its patients on Long Island, New York. , ... well being, and is one of the biggest trends in dentistry today. ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... BURNIE, Md. , May 10, 2017 ... retention solutions for the clinical research industry, is proud ... www.CSSiEnroll.com . The new website features both enriched ... overall user experience and enhances the company,s already well-established ... the industry. "After many months of ...
(Date:5/9/2017)... JERUSALEM , May 9, 2017  Oramed ... www.oramed.com ), a clinical-stage pharmaceutical company focused on ... today that the Canadian Intellectual Property Office has ... for Oral Administration of Exenatide". The patent covers ... analog. GLP-1 is an incretin hormone ...
(Date:5/8/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO)., has completed its ... health care service center company based in ... relationship management programs for leading pharmaceutical manufacturers and health ... WRB will join Envoy Health Management, LLC , ... biotech firms, and other service companies. Together, WRB and ...
Breaking Medicine Technology: